Homology Medicines - Delisted Stock
It looks like this equity (FIXX) cannot be resolved or is no longer available, but we have found another equity that may match the characteristics of what you are looking for. Please check QTTB Q32 Bio to make sure you are using current equity.
Homology Medicines cannot be verified against its exchange. It appears that Homology Medicines is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Note that a delisted financial instrument is a security that has been removed from its exchange and is no longer traded publicly. This can occur for various reasons, such as bankruptcy, merger, or failure to meet exchange listing requirements. Delisted instruments can still trade in the over-the-counter (OTC) market, but they are typically less liquid and carry higher risk compared to assets listed on a major exchange. Check all delisted instruments accross multiple markets.
Homology Medicines Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Homology Medicines market risk premium is the additional return an investor will receive from holding Homology Medicines long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Homology Medicines. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Homology Medicines' alpha and beta are two of the key measurements used to evaluate Homology Medicines' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 49.86 | |||
| Semi Deviation | 11.22 | |||
| Standard Deviation | 205.99 | |||
| Variance | 42433.07 |
Try Other Suggestions
Delisting Warning - FIXX
Homology Medicines was delisted
| The entity Homology Medicines with a symbol FIXX was delisted from NASDAQ Exchange. Please try Q32 Bio with a symbol QTTB from now on. Check all delisted instruments accross multiple markets. |
Homology Medicines Corporate Management
Elected by the shareholders, the Homology Medicines' board of directors comprises two types of representatives: Homology Medicines inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Homology. The board's role is to monitor Homology Medicines' management team and ensure that shareholders' interests are well served. Homology Medicines' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Homology Medicines' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael MBA | Chief Officer | Profile | |
| Melissa Gelormini | Senior Resources | Profile | |
| Saswati Chatterjee | CoFounder Board | Profile | |
| CPA Michaud | Corporate Finance | Profile | |
| Deborah Kinch | Chief Officer | Profile | |
| Julie MD | Sr Operations | Profile |
Still Interested in Homology Medicines?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Homology Stock
If you are still planning to invest in Homology Medicines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Homology Medicines' history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |